Who is the manufacturer of VINNO 8, VINNO 6, VINNO 5?

Vinno Technology (Suzhou) Co.,Ltd filed the 510(k) submission for VINNO 8, VINNO 6, VINNO 5 (K190120).

What is the FDA product code for VINNO 8, VINNO 6, VINNO 5?

IYN. It is classified under 21 CFR 892.1550 as a Class 2 device in the Radiology panel.

What is the regulatory pathway for VINNO 8, VINNO 6, VINNO 5?

510(k) clearance (submission type: Traditional).

What are the predicate devices for VINNO 8, VINNO 6, VINNO 5?

LOGIQ e (K151028); CX50 Diagnostic Ultrasound System (K162329); eZono™ 4000 Ultrasound System (K140254).

Who can help prepare an FDA 510(k) submission like VINNO 8, VINNO 6, VINNO 5?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

VINNO 8, VINNO 6, VINNO 5

K190120 · Vinno Technology (Suzhou) Co.,Ltd · IYN · Jan 23, 2020 · Radiology

Device Facts

Record ID	K190120
Device Name	VINNO 8, VINNO 6, VINNO 5
Applicant	Vinno Technology (Suzhou) Co.,Ltd
Product Code	IYN · Radiology
Decision Date	Jan 23, 2020
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 892.1550
Device Class	Class 2
Attributes	Pediatric

Intended Use

The device is general purpose diagnostic ultrasound system for use by qualified healthcare professionals. It is applicable for adults, pregnant women, pediatric patients and neonates. The device is intended for ultrasound imaging, measurement and analysis of human body and fluid for multiple clinical applications including: abdominal (GYN and Urology), Thoracic/Pleural, Fetal/Ob, small organ (including breast, thyroid, testes), peripheral vessel, neonatal cephalic, adult cephalic, pediatric, musculo-skeletal (conventional, superficial), trans-rectal, trans-vaginal, cardiac adult, cardiac pediatric, magnetic Needle guidance and imaging guidance of interventional procedures (e.g. biopsy). This device is intended to use by, or by the order of, and under the supervision of a licensed physician qualified to direct the use of the device. The device is used in hospital, clinics and clinical point-of-care for diagnosis of patients.

Device Story

Laptop-based digital color ultrasonic diagnostic system; transmits ultrasound waves into body tissues; displays echo images of tissues and blood flow. Input: ultrasound signals from various probes (convex, linear, phased array). Processing: digital acquisition, signal processing, and display. Output: real-time ultrasound images, anatomical measurements, and analysis packages. Includes VGuide NGS function for real-time spatial positioning and visualization of magnetized needles relative to ultrasound image. Used in hospitals, clinics, and point-of-care settings by qualified healthcare professionals/physicians. Benefits: provides diagnostic imaging and interventional guidance for various clinical applications; aids in clinical decision-making through visualization and measurement.

Clinical Evidence

Bench testing only. Biocompatibility per ISO 10993-1:2009; electrical safety/EMC per IEC 60601-1, IEC 60601-2-37, and IEC 60601-1-2; acoustic output per NEMA UD2 and IEC 60601-2-37. Software verification and validation conducted per FDA guidance for moderate level of concern.

Technological Characteristics

Laptop design with integrated battery or external power; 15.6-inch LCD. Probe housing: ABS; lens: Silicon rubber (ISO 10993 compliant). Modes: B, M, Color Flow, PDI, PWD, CWD, Harmonic, 3D/4D, Color M, Elastography, TVI/TVD, Contrast agent imaging. Connectivity: LAN, USB, HDMI, Bluetooth. Standards: IEC 60601-1, IEC 60601-1-2, IEC 60601-2-37, NEMA UD 2.

Indications for Use

Indicated for adults, pregnant women, pediatric patients, and neonates for ultrasound imaging, measurement, and analysis of human body and fluid. Applications: abdominal (GYN/Urology), thoracic/pleural, fetal/OB, small organ (breast, thyroid, testes), peripheral vessel, neonatal/adult cephalic, pediatric, musculoskeletal (conventional/superficial), transrectal, transvaginal, cardiac (adult/pediatric), magnetic needle guidance, and interventional procedure guidance (e.g., biopsy). Prescription use only.

Regulatory Classification

Identification

An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Predicate Devices

LOGIQ e (K151028)
CX50 Diagnostic Ultrasound System (K162329)
eZono™ 4000 Ultrasound System (K140254)

Related Devices

K221911 — VINNO 6PRO, VINNO 6EXP, VINNO 5PRO, VINNO 5EXP, VINNO 3, VINNO 3PRO, VINNO 3EXP · Vinno Technology (Suzhou) Co.,Ltd · Dec 21, 2022
K153037 — LOGIQ V1/ LOGIQ V2 · GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · Jan 4, 2016
K043452 — TITAN HIGH RESOLUTION ULTRASOUND SYSTEM AND SONOSITE ULTRASOUND SYSTEM · Sonosite,Inc. · Dec 21, 2004
K153626 — SonoSite Edge II Ultrasound System · FUJIFILM Sonosite, Inc. · Jan 20, 2016
K180461 — Navi e/Navi s/Navi X Diagnostic Ultrasound System · Shenzhen Wisonic Medical Technology Co. , Ltd. · May 9, 2018

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text. VINNO Technology (Suzhou) Co., Ltd. % Ms. Sherry Zhang Regulatory Affairs 5F Building A, 4F Building C No. 27 XinFa Rd. Suzhou Industrial Park Suzhou, Jiangsu 215123 CHINA January 23, 2020 # Re: K190120 Trade/Device Name: VINNO 8, VINNO 6, VINNO 5 Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: Class II Product Code: IYN, IYO, ITX Dated: December 6, 2019 Received: December 9, 2019 Dear Ms. Zhang: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part {1}------------------------------------------------ 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Michael D'Hara For Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for use DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below. Indications for Use 510(k) Number (if known) K190120 Device Name VINNO 8, VINNO 6, VINNO5 Indications for Use (Describe) The device is general purpose diagnostic ultrasound system for use by qualified healthcare professionals. It is applicable for adults, pregnant women, pediatric patients and neonates. The device is intended for ultrasound imaging, measurement and analysis of human body and fluid for multiple clinical applications including: abdominal (GYN and Urology), Thoracic/Pleural, Fetal/Ob, small organ (including breast, thyroid, testes), peripheral vessel, neonatal cephalic, pediatric, musculo-skeletal (conventional, superficial), transrectal, trans-vaginal, cardiac adult, cardiatric, magnetic Needle guidance and imaging guidance of interventional procedures (e.g. biopsy). This device is intended to use by, or by the order of, and under the supervision of a licensed physician qualified to direct the use of the device. The device is used in hospital, clinics and clinical point-of-care for diagnosis of patients. | Type of Use (Select one or both, as applicable) | ☑ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | |-------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| |-------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ***DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*** The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov *"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."* FORM FDA 3881 (7/17) Page 1 of 1 PSC Publishing Services (301) 443-6740 {3}------------------------------------------------ # 510(k) summary #### l Submitter Device submitter: VINNO Technology (Suzhou) Co., Ltd. 5F Building A, 4F Building C No. 27 XinFa Rd. Suzhou Industrial Park, SuZhou 215123 Jiangsu China Contact person: Sherry Zhang Regulatory Affairs Phone: +86 15850113783 Fax: +86 512 62873801 Email: Sherry.Zhang@vinno.com Date of preparation: Dec 5th, 2019 #### II Device Trade Name of Device: VINNO 8, VINNO 6, VINNO 5 Regulation name: Ultrasonic pulsed doppler imaging system Regulation Number: 21 CFR 892.1550 Requlatory Class: II Product code: IYN, IYO, ITX #### III Predicate Devices Trade name: LOGIQ e Regulation Name: Ultrasonic pulsed doppler imaging system Regulation Number: 21 CFR 892.1550 Regulatory Class: II Product code: IYN, IYO, ITX Premarket Notification: k151028 Trade name: CX50 Diagnostic Ultrasound System Regulation Name: Ultrasonic pulsed doppler imaging system Regulation Number: 21 CFR 892.1550 Regulatory Class: II Product code: IYN, IYO, ITX Premarket Notification: k162329 Trade name: eZono™ 4000 Ultrasound System Regulation Name: Ultrasonic pulsed doppler imaging system Regulation Number: 21 CFR 892.1550 {4}------------------------------------------------ Requlatory Class: II Product code: IYN, IYO, ITX Premarket Notification: k140254 ## IV Device description The VINNO 8, VINNO 6, VINNO 5 ultrasound devices are laptop digital color ultrasonic diagnostic devices which transmit ultrasound waves into the body tissues and display the echo images of the tissues and blood flow accordingly. The devices are capable of digital acquisition, processing and display and operate from an integrated battery or separate power supply/charger. Mode of operations for each probe supported by the VINNO 8, VINNO 6, VINNO 5 ultrasound devices is listed in below table. | Probe | B | M | PWD | CWD | Tissue Doppler | Color Doppler | Color M Doppler | Power Doppler | Tissue Velocity | Imaging Harmonic | Imaging 3D/4D | CBI | EI | Combine modes[1] | VINNO 5 | VINNO 6 | VINNO 8 | |---------|---|---|-----|-----|-------------------|------------------|--------------------|------------------|--------------------|---------------------|------------------|-----|----|---------------------|---------|---------|---------| | G2-5C | N | N | N | N | N | N | N | N | N | N | N | N | N | N | | | X | | U5-15LE | N | N | N | N | N | N | N | N | N | N | N | N | N | N | | | X | | S1-6P | N | N | N | N | N | N | N | N | N | N | N | N | N | N | | | X | | F2-5C | N | N | N | N | N | N | N | N | N | N | N | N | N | N | X | X | X | | F4-9E | N | N | N | N | N | N | N | N | N | N | N | N | N | N | X | X | X | | G4-9M | N | N | N | N | N | N | N | N | N | N | N | N | N | N | X | X | X | | F4-12L | N | N | N | N | N | N | N | N | N | N | N | N | N | N | X | X | X | | D3-6C | N | N | N | N | N | N | N | N | N | N | N | N | N | N | X | X | X | | G1-4P | N | N | N | N | N | N | N | N | N | N | N | N | N | N | X | X | X | | X4-12L | N | N | N | N | N | N | N | N | N | N | N | N | N | N | | X | X | | X6-16L | N | N | N | N | N | N | N | N | N | N | N | N | N | N | | X | X | | X6-16LG | N | N | N | N | N | N | N | N | N | N | N | N | N | N | | X | X | Note: N = new indication; P = previously cleared by FDA [1] Combined modes are: B/M, B/Color M, B/PWD, B/Color/PWD, B/Power/PWD; The systems also provide for the measurement of anatomical structures and for analysis packages that provide information that is used for clinical diagnosis purposes. The VGuide NGS function detects the position and orientation of magnetized needles in {5}------------------------------------------------ the presence of the probe and displays this information relative to the ultrasound image. Spatial positioning of the needle, with respect to the ultrasound image, is then updated in real time. This guides the operator to better visualize the needle in the ultrasound image during ultrasound guided needling procedures. {6}------------------------------------------------ #### V Indications for use The device is general purpose diagnostic ultrasound system for use by qualified healthcare professionals. It is applicable for adults, pregnant women, pediatric patients and neonates. The device is intended for ultrasound imaging, measurement and analysis of human body and fluid for multiple clinical applications including: abdominal (GYN and Urology), Thoracic/Pleural, Fetal/Ob, small organ (including breast, thyroid, testes), peripheral vessel, neonatal cephalic, adult cephalic, pediatric, musculo-skeletal (conventional, superficial), trans-rectal, trans-vaginal, cardiac adult, cardiac pediatric, magnetic Needle guidance and imaging guidance of interventional procedures (e.g. biopsy). This device is intended to use by, or by the order of, and under the supervision of a licensed physician qualified to direct the use of the device. The device is used in hospital, clinics and clinical point-of-care for diagnosis of patients. {7}------------------------------------------------ The detail indications for use of each probe are listed below. | | | Anatomy/Region of Interest | | | | | | | | Exam Type, Means of Access | | | | | | | Interventional Guidance | | | | |------------|-------|----------------------------|-----------|-----------------|-------------------|----------------|---------------|-------------------|-------------------|---------------------------------|--------------------------------|------------------|--------------|---------------|----------------|-----------------|-------------------------|-----------------|-----------------|---| | Transducer | Fetal | Abdominal | Pediatric | Small Organ [2] | Neonatal Cephalic | Adult Cephalic | Cardiac Adult | Cardiac Pediatric | Peripheral vessel | Musculo-skeletal (Conventional) | Musculo-skeletal (Superficial) | Thoracic/Pleural | Trans-rectal | Trans-vaginal | Trans-urethral | Transesophageal | Intraoperative | Vascular Access | Nonvascular [1] | | | G2-5C | N | N | N | | | | | | | | | | | | | | | | N | | | U5-15LE | | N | N | N | | | | | N | N | N | | | | | | | | N | | | S1-6P | | N | N | | N | N | N | N | | | | | | | | | | | N | | | X6-16L | | N | N | N | | | | | N | N | N | | | | | | | | N | | | X6-16LG | | N | N | N | | | | | N | N | N | | | | | | | | N | | | F2-5C | N | N | N | | | | | | | | | | | | | | | | N | | | F4-9E | N | N | | | | | | | | | | | N | N | | | | | N | | | G4-9M | | N | N | | N | | N | N | | | | | | | | | | | | N | | F4-12L | | N | N | N | | | | | N | N | N | | | | | | | | N | | | X4-12L | | N | N | N | | | | | N | N | N | | | | | | | | N | | | D3-6C | N | N | | | | | | | | | | | | | | | | | | | | G1-4P | | N | N | | N | N | N | N | | | | | | | | | | | | N | Notes: {8}------------------------------------------------ N = new indication; P = previously cleared by FDA [1] Nonvascular means Biopsy Guidance [2] Small organs include breast, testes, thyroid {9}------------------------------------------------ ## VI Comparison of technological characteristics with the predicate devices The VINNO 8, VINNO 6, VINNO 5 ultrasound devices have the same technological characteristics and fundamental design as the predicate devices. The VINNO 8, VINNO 6, VINNO 5 ultrasound devices and the predicate device are all lap-top general purpose ultrasound devices designed to provide real-time images for diagnosis. The differences between the VINNO 8, VINNO 6, VINNO 5 ultrasound devices and predicate devices do not alter suitability of the proposed device for its intended use. {10}------------------------------------------------ | Device feature | VINNO 8, VINNO 6, VINNO 5 (subject device) | GE Healthcare LOGIQ e k151028 (predicate device) | Philips CX50 Diagnostic Ultrasound System k162329 (predicate device) | |------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Indications for use | The device is intended for ultrasound imaging, measurement and analysis of human body and fluid for multiple clinical applications including: abdominal (GYN and Urology), Thoracic/Pleural, Fetal/Ob, small organ (including breast, thyroid, testes), peripheral vessel, neonatal cephalic, adult cephalic, pediatric, musculo-skeletal (conventional, superficial), trans-rectal, trans-vaginal, cardiac adult, cardiac pediatric, magnetic Needle guidance and imaging guidance of interventional procedures (e.g. biopsy). | The LOGIQ e is intended for ultrasound imaging, measurement and analysis of the human body for multiple clinical applications including: ophthalmic: fetal/ob; abdominal (gyn & urology); pediatric; small organ (breast, testes, thyroid); neonatal and adult cephalic; cardiac (adult & pediatric); peripheral vascular; musculoskeletal conventional & superficial; transrectal; transvaginal; transesophageal; intraoperative (abdominal, thoracic and peripheral); thoracic/pleural for motion and fluid detection and imaging guidance of interventional procedures (e.g. Nerve block; vascular access). | Ophthalmic, Intraoperative, Laparascopic, Fetal, Abdominal, Pediatric, Small Organ, Adult Cephalic, Neonatal Cephalic, Trans-vaginal, Musculoskeletal, Gynecological, Cardiac Adult, Cardiac Pediatric, Trans-esoph, Intracardiac echo, Peripheral Vessel, Other (Carotid) | | User | Qualified healthcare | Qualified physicians or | Qualified physicians or | | qualification | professionals | sonographers | sonographers | | Physical Design | Laptop design with lithium battery, also available to be used with a mobile cart 1 probe port | Laptop design with lithium battery, also available to be used with a mobile cart 1 probe port | Laptop design with lithium battery, also available to be used with a mobile cart 1 probe port | | Patient contact materials | Probe housing: ABS, Probe lens: Silicon rubber Comply with ISO10993 series | Probe housing: ABS Probe lens: Silicon rubber Comply with ISO10993 series | Probe housing: ABS Probe lens: Silicon rubber Comply with ISO10993 series | | Operating modes | B, M, Color Flow, PDI, PWD, CWD, Harmonic, 3D/4D, Color M, Elastography, TVI/TVD, Contrast agent imaging | B, M, M-Color Flow, Anatomical M, Color Anatomical M, CFM, PDI, High-Res PDI, CWD, PWD, TVI/TVD, Needle Recognition, 3D | B, M, Anatomical M, Color M, Color, CWD, Harmonic, PDI, PWD, TDI, Power/Dirpower, 3D/4D, Elastography, Stress Echo, Contrast agent imaging | | Operating controls | Gain, Depth, Focus, TGC, B Steer, 2D Automatic Optimization, Harmonic Imaging, L/R, U/D, Frequency, PRF, Wall Filter, Packet Size, Color Level, Invert, Color Map, Line Density, Sync Display, Persistence, Flash Reduction, Base Line, Transparency, Steer, Focus Position, Focus Number, VFusion, VSpeckle, Dynamic Range | Depth, Gain, Focus, Auto Optimize, MD cursor, Frequency, CrossXBeam, TGC, Tilt, Reserve, Dynamic Range, Line Density, Grey Maps, Frame Average, Colorize, Edge Enhance, Steer, Rotation, Virtual Convex, SRI HD, Virtual Apex, Centerline, Rejection, Suppression, Scan Area, LOGIQ View, Fusion Background Area, | Depth, Gain, Dynamic Range, TGC, Angle, Color Gain, Wall Filter, Baseline, Sweep Speed, Doppler DR, Colorize, iBeam, iClear, TSI, Sync Display, Steer, Focus Position, Focus Number, iTouch | | Measurements | Depth, Distance, Perimeter, Area, | Depth, Distance, Circumference, | Depth, Distance, Circumference, | | | Volume, Angle, Stenosis, A/B ratio, Time, Speed, Heart Rate, Stenosis, A/B ratio, Acceleration, PS, ED, TAMAX, TAMEAN, RI, PI, PS.ED ratio, ED/PS ratio, Flow volume, MaxPG, MeanPG, Stroke Volume, Heart rate | Area, Angle, Stenosis, A/B ratio, Slope, Heart Rate, Velocity, Time, Acceleration, Frequency, TAMAX, TAMEAN, RI, PI, Ratios, Heart rate, Auto Doppler Trace function with automatic calculations | Area, Time, Heart Rate, Angle, Stenosis, A/B ratio, Volume, Auto volume measurements, Auto NT measurements, Auto OB measurement, Color Speed, Orthopaedic surgery | | Comments | Comments and bodymarks | Comments and bodymarks | Comments and bodymarks | | Probe types | Convex array Linear array Phased array | Convex array Linear array Sector array | Curved array Linear array Phased array | | Display monitor | 15.6 inch LCD monitor | 15 inch LCD monitor | 15.6 inch LCD monitor | | Acoustic output | Comply with Track 3 limits: $Ispta.3≤720mW/cm²$ $MI≤1.9$ | Comply with Track 3 limits: $Ispta.3≤720mW/cm²$ $MI≤1.9$ | Comply with Track 3 limits: $Ispta.3≤720mW/cm²$ $MI≤1.9$ | | Conformity standards | IEC6061-1 IEC60601-1-2 IEC60601-2-37 NEMA UD 2 | IEC6061-1 IEC60601-1-2 IEC60601-2-37 NEMA UD 2 | IEC6061-1 IEC60601-1-2 IEC60601-2-37 NEMA UD 2 | | Peripherals | LAN, USB storage device, HDMI, Footswitch, Printers, ECG lead, Mobile Cart, USB Bluetooth | LAN, USB storage device, HDMI, Footswitch, Printers, USB ECG, Barcode Scanner, External DVD R/W, Mobile Cart | LAN, USB storage device, HDMI, Footswitch, Printers, USB ECG, Barcode Scanner, External DVD R/W, Mobile Cart | Table 1 Substantial equivalence discussion {11}------------------------------------------------ {12}------------------------------------------------ {13}------------------------------------------------ ### VII Performance data The following performance data were provided in support of the substantial equivalence determination. ## Biocompatibility testing Biocompatibility of the probes was evaluated in accordance with ISO 10993-1:2009. All evaluation acceptance criteria were met ## Electrical safety and electromagnetic compatibility (EMC) Electrical safety and EMC testing were conducted on the Ultrasound System. The system complies with the IEC 60601-1 and IEC 60601-2-37 for safety and the IEC 60601-1-2 for EMC. # Software Verification and Validation Testing Software verification and validation testing were conducted and documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices." The software for this device was considered as a "moderate" level of concern. ## Acoustic output testing Acoustic output testing was performed according to NEMA UD2 and IEC60601-2-37. # VIII Conclusion The VINNO 8, VINNO 6, VINNO 5 ultrasound devices are substantially equivalent to their predicate devices. The non-clinical testing demonstrates that the device is as safe, as effective and performs as well as the legally marketed device.